home / stock / acxp / acxp news

ACXP News and Press, Acurx Pharmaceuticals Inc. From 07/07/23

Stock Information
Company Name: Acurx Pharmaceuticals Inc.
Stock Symbol: ACXP
Market: NASDAQ
Website: acurxpharma.com
Menu
ACXP ACXP Quote ACXP Short ACXP News ACXP Articles ACXP Message Board
Get ACXP Alerts

News, Short Squeeze, Breakout and More Instantly...
ACXP - New to The Street Airs its Televised Corporate Interviews on Newsmax and The FOX Business Network, Episodes 486 and 487; Broadcastings Begin Saturday, July 8, 2023, at 3:30 PM ET

NEW YORK, July 07, 2023 (GLOBE NEWSWIRE) -- New to The Street , an FMW Media production, will air its corporate interviews, episodes 486 and 487, on Newsmax and the FOX Business Network . The Following Corporate interviews will air on Newsmax, episode 486, Saturd...
ACXP - New to The Street TV / Newsmax TV Announces its Five Corporate Interviews on Episode 484, Airing Saturday, July 01, 2023, 3:30 PM ET

NEW YORK, June 30, 2023 (GLOBE NEWSWIRE) -- FMW Media's New to The Street / Newsmax announces its 484th show line-up, which features five (5) Corporate interviews, airing Saturday, July 01, 2023, 3:30-4:00 PM ET. 1). Biopharmaceutical – Acurx Pharmaceuticals, Inc....

ACXP - Acurx Pharmaceuticals to Participate in the Maxim Group LLC Virtual Healthcare Conference on Tuesday, June 20, 2023 to Thursday, June 22, 2023 at 9 am ET

Acurx Pharmaceuticals to Participate in the Maxim Group LLC Virtual Healthcare Conference on Tuesday, June 20, 2023 to Thursday, June 22, 2023 at 9 am ET PR Newswire STATEN ISLAND, N.Y. , June 15, 2023 /PRNewswire/ -- Acurx Pharmaceuticals (Nasdaq: ACXP), a ...

ACXP - Seres Therapeutics: Still Work To Do Before Realizing Its Potential

2023-05-22 14:49:12 ET Summary SER-109 (Vowst) was recently approved by FDA and will be launched in June with the Nestle commercial team. Most of the pipeline has failed in clinical trials. There is one active, albeit early stage clinical program, SER -155. The company bur...
ACXP - Acurx Pharmaceuticals down 10% on $4M offering

2023-05-16 09:10:30 ET Clinical stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat bacterial infections, Acurx Pharmaceuticals ( NASDAQ: ACXP ) enters into a securities purchase agreement with a single institutional investor to pu...

ACXP - Acurx Pharmaceuticals, Inc. Announces Pricing of $4.0 Million Registered Direct Offering

Acurx Pharmaceuticals, Inc. Announces Pricing of $4.0 Million Registered Direct Offering PR Newswire STATEN ISLAND, N.Y. , May 16, 2023 /PRNewswire/ -- Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a clinical stage biopharmaceutical compa...

ACXP - Acurx Pharmaceuticals, Inc. (ACXP) Q1 2023 Earnings Call Transcript

2023-05-12 10:33:08 ET Acurx Pharmaceuticals, Inc. (ACXP) Q1 2023 Earnings Conference Call May 12, 2023, 08:00 AM ET Company Participants Rob Shawah - CFO Dave Luci - President and CEO Conference Call Participants Jim Molloy - Alliance Global Partners ...
ACXP - Acurx Pharmaceuticals GAAP EPS of -$0.25

2023-05-12 07:02:59 ET Acurx Pharmaceuticals press release ( NASDAQ: ACXP ): Q1 GAAP EPS of -$0.25. The Company ended the quarter, with cash totaling $7.2 million compared to $9.1 million as of December 31, 2022. For further details see: Acurx Pharmaceuticals GAA...

ACXP - Acurx Pharmaceuticals, Inc. Reports First Quarter 2023 Results and Provides Business Update

Acurx Pharmaceuticals, Inc. Reports First Quarter 2023 Results and Provides Business Update PR Newswire STATEN ISLAND, N.Y. , May 12, 2023 /PRNewswire/ -- Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a clinical stage bioph...

ACXP - Acurx Pharmaceuticals to Discuss First Quarter 2023 Financial Results and Provide Business Update

Acurx Pharmaceuticals to Discuss First Quarter 2023 Financial Results and Provide Business Update PR Newswire STATEN ISLAND, N.Y. , May 5, 2023 /PRNewswire/ -- Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a clinical stage biopharmaceutic...
Previous 10 Next 10